PBE vs. GK ETF Comparison
Comparison of PowerShares Dynamic Biotech & Genome (PBE) to AdvisorShares Gerber Kawasaki ETF (GK)
PBE
PowerShares Dynamic Biotech & Genome
PBE Description
The PowerShares Dynamic Biotechnology & Genome Portfolio (Fund) is based on the Dynamic Biotech & Genome IntellidexSM Index (Intellidex Index). The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Intellidex Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including price momentum, earnings momentum, quality, management action, and value. The Underlying Intellidex Index is comprised of common stocks of 30 US biotechnology and genome companies. These are companies that are principally engaged in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes and companies that benefit significantly from scientific and technological advances biotechnology and genetic engineering and reseach. The Fund and the Index are rebalanced and reconstituted quarterly in February, May, August and November.
Grade (RS Rating)
Last Trade
$69.51
Average Daily Volume
8,248
30
GK
AdvisorShares Gerber Kawasaki ETF
GK Description
GK seeks to provide a broad thematic exposure by actively investing in a growth-focused portfolio of US companies across a variety of long-term macro trends. It uses a multi-thematic approach to concentrate on disruptive investment themes while ensuring diversification across holdings. In selecting stocks, the fund adviser uses a three-part system which involves fundamental, technical, and qualitative analysis on firms that could benefit from long-term changes in the market. The funds investments may be of any market capitalization and may focus on innovative companies related to renewable energy and sustainable transportation, technology frontiers, video gaming and Esports, cannabis, online gambling, top consumer brands, pet and animal wellness, real estate disruption, healthcare and biotechnology, and the media industry. The fund seeks long-term capital appreciation.Grade (RS Rating)
Last Trade
$21.40
Average Daily Volume
4,174
28
Performance
Period | PBE | GK |
---|---|---|
30 Days | -0.58% | 5.46% |
60 Days | 4.92% | 12.60% |
90 Days | 7.62% | -1.83% |
12 Months | 22.81% | 31.76% |
1 Overlapping Holdings
Symbol | Grade | Weight in PBE | Weight in GK | Overlap | |
---|---|---|---|---|---|
REGN | D | 4.48% | 2.49% | 2.49% |
PBE Overweight 29 Positions Relative to GK
Symbol | Grade | Weight | |
---|---|---|---|
UTHR | C | 5.26% | |
ILMN | B | 5.1% | |
AMGN | D | 5.05% | |
ALNY | C | 5.03% | |
BIIB | F | 4.88% | |
BMRN | F | 3.98% | |
NBIX | F | 3.87% | |
XNCR | D | 3.28% | |
MNKD | B | 3.27% | |
NVAX | C | 3.17% | |
TECH | D | 3.14% | |
PTGX | C | 2.98% | |
VCYT | C | 2.97% | |
NTRA | A | 2.95% | |
COLL | A | 2.86% | |
RGEN | F | 2.85% | |
TGTX | D | 2.83% | |
EXEL | B | 2.82% | |
INCY | B | 2.81% | |
BPMC | F | 2.78% | |
MYGN | D | 2.78% | |
QGEN | F | 2.77% | |
CDNA | B | 2.74% | |
ACAD | F | 2.73% | |
CPRX | C | 2.71% | |
BCRX | D | 2.58% | |
HALO | D | 2.53% | |
OPK | D | 2.52% | |
VCEL | F | 2.2% |
PBE Underweight 27 Positions Relative to GK
Symbol | Grade | Weight | |
---|---|---|---|
MSFT | D | -7.7% | |
NVDA | B | -7.7% | |
AAPL | C | -6.56% | |
LEN | C | -6.24% | |
MGM | D | -5.95% | |
NVO | F | -5.83% | |
TT | A | -5.43% | |
NFLX | A | -4.96% | |
GOOG | B | -4.94% | |
DIS | D | -4.25% | |
BX | C | -3.96% | |
AMZN | C | -3.47% | |
ORCL | A | -3.2% | |
AVGO | B | -3.16% | |
LPLA | D | -2.85% | |
HD | A | -2.63% | |
DELL | C | -2.57% | |
ASML | F | -2.56% | |
VICI | C | -2.42% | |
AMD | C | -1.57% | |
UBER | C | -1.53% | |
MSOS | D | -1.3% | |
ONON | A | -1.03% | |
SYK | C | -0.96% | |
TSLA | C | -0.68% | |
GD | C | -0.47% | |
ZTS | C | -0.43% |
PBE: Top Represented Industries & Keywords
GK: Top Represented Industries & Keywords